Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Japan.
J Neurol Sci. 2012 Feb 15;313(1-2):189-92. doi: 10.1016/j.jns.2011.09.013. Epub 2011 Oct 5.
A Japanese family with a novel nonsense mutation in the TITF-1 gene (p.Y98X) is described. The proband showed severe generalized chorea, delayed motor development, subnormal intelligence, congenital hypothyroidism, bronchial asthma, and a history of pulmonary infection, all of which are characteristic features of Brain-Thyroid-Lung syndrome. On the other hand, her brother and mother showed a mild benign hereditary chorea (BHC) phenotype with congenital hypothyroidism. Intrafamilial phenotypic variation is common in BHC/Brain-Thyroid-Lung syndrome and suggests the existence of other genetic or environmental factors regulating TITF-1 function. Although choreic movement in BHC/Brain-Thyroid-Lung syndrome is recognized as non-progressive, the proband showed re-exacerbation of choreic movement at puberty. The dopamine agonist, ropinirole hydrochloride, reduced her choreic movements, suggesting that levodopa and/or dopamine agonists may compensate for underdeveloped dopaminergic pathways in this disorder.
一个日本家族携带 TITF-1 基因(p.Y98X)的新型无义突变,该基因与脑-甲状腺-肺综合征相关。先证者表现为严重的全身性舞蹈病、运动发育迟缓、智力低下、先天性甲状腺功能减退、支气管哮喘和肺部感染史,这些都是脑-甲状腺-肺综合征的特征性表现。另一方面,她的哥哥和母亲表现为轻度良性遗传性舞蹈病(BHC)合并先天性甲状腺功能减退。BHC/脑-甲状腺-肺综合征患者的家族内表型变异很常见,提示存在其他调节 TITF-1 功能的遗传或环境因素。虽然 BHC/脑-甲状腺-肺综合征的舞蹈病运动被认为是不会进展的,但先证者在青春期出现了舞蹈病运动的再次加重。多巴胺激动剂罗匹尼罗盐酸盐减少了她的舞蹈病运动,这表明左旋多巴和/或多巴胺激动剂可能补偿了该疾病中发育不良的多巴胺能通路。